Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related event
Related Products
Reset
TitlePublishedTypeProducts
A knowledge-based approach to the in silico assessment of toxicity .pdfMay 2010pdf fileDerek NexusMeteor Nexus
A Look at Lhasa's Future Integrated WorkflowsMarch 2018pdf file
A pharma-wide approach to address the genotoxicity prediction of primary aromatic amines.June 2018
A practical application of two in silico systems for identification of potentially mutagenic impuritiesMay 2015Derek NexusSarah Nexus
A quantitative in silico model for predicting skin sensitization using a nearest neighbours approach within expert-derived structure–activity alert spacesMarch 2017Derek Nexus
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicityApril 2006
A Suggested ICH M7 Framework Using Lhasa Limited ProductsMarch 2018pdf fileZenethVitic NexusMirabilisSarah NexusDerek Nexus
A technetium intermediate specifically promotes deprotection of trifluoroacetyl HYNIC during radiolabelling under mild conditionsApril 2008
A tool for predicting the purging of (potentially) mutagenic impurities during synthesisMarch 2016pdf fileMirabilis
A Tool to Assist Toxicological Knowledge Development by Mining Emerging Patterns from Toxic.pdfSeptember 2012pdf fileDerek Nexus
Acceptable Intake and Permitted Daily Exposure Data Sharing Project for Pharmaceutical ImpuritiesSeptember 2017Vitic Nexus
Acceptable Intake and Permitted Daily Exposure Data Sharing Project for Pharmaceutical ImpuritiesOctober 2017pdf file
Adding In Vivo Mammalian Cytogenetics Data to SEND and ToxML.pdfMarch 2015pdf file
Addressing the Challenge of Making Negative Predictions for Skin SensitisationMarch 2018pdf fileDerek Nexus
Addressing the Challenge of Making Negative Predictions for Skin Sensitisation - A SummaryApril 2018Derek Nexus
Addressing toxicity risk when designing and selecting compounds in early drug discoveryJanuary 2014Derek Nexus
Addressing toxicity risk.pdfJune 2014pdf fileDerek Nexus
Adjustment FactorsMay 2018pdf file
Advances in In Silico Skin Sensitisation Predictions Using Derek NexusOctober 2017pdf fileDerek Nexus
Advantages in Utilizing an Integrated In Silico Solution for ICH M7 Expert ReviewMarch 2016pdf fileDerek NexusMirabilisSarah NexusVitic NexusZeneth
Advantages in Utilizing an Integrated In Silico Solution for ICH M7 Expert ReviewNovember 2016pdf fileDerek NexusMeteor NexusSarah NexusVitic NexusZeneth
Adverse Outcome Pathways for Developmental Toxicity.pdfSeptember 2011pdf fileDerek Nexus
Adverse outcome pathways for the nephrotoxicity of non-steroidal anti-inflammatory drugs.pdfMarch 2015pdf fileDerek Nexus
AI and PDE Data Sharing Projects for Pharmaceutical ImpuritiesMay 2018pdf file
Alternatives to in vivo testing for plant protection productsOctober 2017pdf fileDerek Nexus

© 2018 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.